Agonist-induced [35S]GTPγS binding in the membranes of Spodoptera. Frugiperda insect cells expressing the human D3 dopamine receptor

Neuroscience Letters

Volumn 226, Issue 2, 1997, Pages 91-94

  Pregenzer, Jeffrey F ^a   Alberts, Glen L ^a   Bin Im, Wha ^a  

^a PFIZER INC   (United States)

Author keywords

35S GTP S binding; D3 dopamine receptor; G protein activation; Spodoptera frugiperda insect cells

Indexed keywords

DOPAMINE; DOPAMINE 3 RECEPTOR; EMONAPRIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE DERIVATIVE; N ETHYLMALEIMIDE; QUINPIROLE; BENZAMIDE DERIVATIVE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DRD3 PROTEIN, HUMAN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); HYBRID PROTEIN; SULFUR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INSECT; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; ANIMAL; ARMYWORM; BIOSYNTHESIS; CELL LINE; CELL MEMBRANE; GENETIC TRANSFECTION; KINETICS; METABOLISM;

ANIMALS; BENZAMIDES; CELL LINE; CELL MEMBRANE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; ETHYLMALEIMIDE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; KINETICS; QUINPIROLE; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECOMBINANT FUSION PROTEINS; SPODOPTERA; SULFUR RADIOISOTOPES; TRANSFECTION;

EID: 0030611298     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00251-6     Document Type: Article

References (19)

1. Boundy V.A., Luedtke R.R., Gallitano A.L., Smith L.E., Filtz T.M., Kallen R.G., Molinoff P.B. Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies. J. Pharmacol. Exp. Ther. 264:1993;1002-1011.
2. Boundy V.A., Lu L., Molinoff P.B. Differential coupling of rat D2 dopamine receptor isoforms expressed in Spodoptera frugiperda insect cells. J. Pharmacol. Exp. Ther. 276:1996;784-794.
3. 1A receptor on Sf-9 cells. J. Biol. Chem. 270:1995;18691-18699.
4. Chabert C., Cavegn C., Bernard A., Mills A. Characterization of the functional activity of dopamine ligands at human recombinant dopamine D4 receptors. J. Neurochem. 63:1994;62-65.
5. Chio C.L., Lajiness M.E., Huff R.M. Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors. Mol. Pharmacol. 45:1994;51-60.
6. Civelli O., Bunzow J.R., Grandy D.K. Molecular diversity of the dopamine receptors. Annu. Rev. Pharmacol. Toxicol. 32:1993;281-307.
7. Cohen A.I., Todd R.D., Harmon S., O'Malley K.L. Photoreceptors of mouse retinas possess D4 receptors coupled to adenylate cyclase. Proc. Natl. Acad. Sci. USA. 89:1992;12093-12097.
8. Griffon N., Pilon C., Schwartz J.-C., Sokoloff P. The preferential dopamine D3 receptor ligand, (+)-UH232, is a partial agonist. Eur. J. Pharmacol. 282:1995;R3-R4.
9. Lew M.J., Angus J. Analysis of competitive agonist-antagonist interactions by nonlinear regression. Trends Pharmacol. Sci. 16:1995;328-337.
10. o-like G-protein(s). J. Biol. Chem. 269:1994;12954-12962.
11. Nakajima T., Irisawa H., Giles W. N-Ethylmaleimide uncouples muscarinic receptors from acetylcholine-sensitive potassium channels in bullfrog atrium. J. Gen. Physiol. 96:1990;887-903.
12. Ng G.Y.K., O'Dowd B.F., Caron M., Dennis M., Brann M.R., George S.R. Phosphorylation and palmitoylation of the human D2L dopamine receptor in Sf9 cells. J. Neurochem. 63:1994;1589-1595.
13. A receptors of the α1β2 and α1β2γ2 subtypes. Mol. Pharmacol. 43:1993;801-806.
14. 1 pituitary cells. FEBS Lett. 312:1992;123-126.
15. Seeman P., Van Tol H.M. Dopamine receptor pharmacology, Trends Pharmacol. Sci. 15:1994;264-270.
16. Sokoloff P., Giros B., Martres M.-P., Bouthenet M.L., Schwartz J.-C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target of neuroleptics. Nature. 347:1990;146-151.
17. Sokoloff P., Schwartz J.-C. Novel dopamine receptors half a decade later. Trends Pharmacol. Sci. 16:1995;270-275.
18. Tang L., Todd R.D., Heller A., O'Malley K.L. Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. J. Pharmacol. Exp. Ther. 268:1994;495-502.
19. Winslow J.W., Bradley J.D., Smith J.A., Neer E.J. Reactive sulfhydryl groups of a 39 nucleotide-binding protein from brain. J. Biol. Chem. 262:1987;4501-4507.